A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

BACKGROUND: Obtaining tissue for pancreatic carcinoma diagnosis and biomarker assessment to aid drug development is challenging. Circulating tumour cells (CTCs) may represent a potential biomarker to address these unmet needs. We compared prospectively the utility of two platforms for CTC enumeratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoja, L, Backen, A, Sloane, R, Menasce, L, Ryder, D, Krebs, M, Board, R, Clack, G, Hughes, A, Blackhall, F, Valle, J W, Dive, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273340/
https://www.ncbi.nlm.nih.gov/pubmed/22187035
http://dx.doi.org/10.1038/bjc.2011.545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273340/
https://www.ncbi.nlm.nih.gov/pubmed/22187035
http://dx.doi.org/10.1038/bjc.2011.545

Ejemplares similares